Michael Louis Dworkin, MD
Radiation Oncology · Santa Cruz
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Dominican Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Dworkin’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A166759 · Current
Licensed to practise in California · since 2019 · expires 2027-11-30 · Duke University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Dominican HospitalSanta Cruz, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 68% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Postoperative sepsis rate: 11.66 (8.02 to 15.3) · 412 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.168, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.169, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.489, Oct 2024 – Sep 2025
See every measure and the patient survey for Dominican Hospital
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative sepsis rateComplications and deaths | 11.66 (8.02 to 15.3) · 412 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.168 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.169 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.489 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0.06 to 1.95) · 1,248 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.14 (0.85 to 1.43) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 134.37 (94.33 to 174.41) · 132 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 54 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 137 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12 · 228 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.5 · 534 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.8 · 491 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 278 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 2,973 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.14 (0 to 0.34) · 7,510 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,695 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.42 (1.44 to 5.4) · 1,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.26 (0 to 2.76) · 436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.85 (0.4 to 3.29) · 1,474 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.73 (3 to 14.46) · 437 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.03) · 343 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.17) · 6,336 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.615 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.937 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 212 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 505 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 45 · 237 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.5 · 594 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.9 · 510 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 473 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.4 to 7.8) · 126 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13 (9.4 to 17.7) · 126 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 12.7 · 43 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.1 (9.4 to 15.4) · 1,585 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 390 cases | No different | Jan 2024 – Dec 2024 |
What patients said (774 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 32% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$1,649,191
Medicare paid this office $1,649,191 for 290 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 84 | $648,952 | $332 |
| Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment | 101 | $193,501 | $96 |
| Ct guidance for insertion of radiation therapy fields | 182 | $184,409 | $107 |
| High precision radiation therapy planning | 85 | $168,654 | $1,687 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 31 | $88,016 | $216 |
See all 23 services
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 84 | $648,952 | $332 |
| Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment | 101 | $193,501 | $96 |
| Ct guidance for insertion of radiation therapy fields | 182 | $184,409 | $107 |
| High precision radiation therapy planning | 85 | $168,654 | $1,687 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 31 | $88,016 | $216 |
| Radiation treatment management, 5 treatment sessions | 140 | $68,491 | $157 |
| Design and construction of radiation treatment device for high precision radiation therapy | 85 | $46,609 | $416 |
| Cranial lesion surgery using radiation over multiple sessions | 13 | $43,914 | $934 |
| Continuing radiation therapy consultation per week | 113 | $37,963 | $82 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 96 | $30,818 | $251 |
| New patient visit (60+ min) | 136 | $24,497 | $180 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 45 | $19,423 | $413 |
| Calculation of radiation therapy dose | 114 | $16,966 | $59 |
| Complex radiation therapy planning | 112 | $15,587 | $134 |
| 3d radiation therapy planning | 28 | $11,984 | $428 |
| Design and construction of complex radiation treatment device | 43 | $9,728 | $112 |
| Management of cranial lesion surgery using radiation over multiple sessions | 14 | $7,380 | $527 |
| Long return visit (40+ min) | 39 | $7,175 | $153 |
| Return visit (30+ min) | 40 | $5,099 | $104 |
| Special radiation treatment | 34 | $3,976 | $117 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 121 | $3,869 | $27 |
| X-ray during radiation therapy | 24 | $910 | $14 |
| Short return visit | 12 | $589 | $49 |
Who their Medicare patients are
290 Original Medicare patients in 2024. Average age 75 · Women 40% · Also on Medicaid 20% · Health risk score 1.51. At or below the middle of the specialty; the typical radiation oncology clinician is at 1.69.
Conditions among them: Cancer 75% · High blood pressure 68% · Diabetes 23% · Chronic kidney disease 21% · Coronary heart disease 19% · Atrial fibrillation 19% · Depression 16% · Heart failure 11% · COPD 11% · Stroke 7%.
The office billed $11,477,756, Medicare allowed $2,073,757 and paid $1,649,191; for 8,615 services of 40 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 290 | 8,615 | 75 | 1.51 | $11,477,756 | $1,649,191 |
| 2023 | 94 | 1,069 | 75 | 1.11 | $1,138,389 | $194,991 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Ct guidance for insertion of radiation therapy fields | 59 | $48,185 | $110 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 17 | $40,330 | $345 |
| High precision radiation therapy planning | 15 | $27,417 | $1,714 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 14 | $21,159 | $225 |
| Radiation treatment management, 5 treatment sessions | 34 | $10,229 | $162 |
| Design and construction of radiation treatment device for high precision radiation therapy | 15 | $7,981 | $420 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 12 | $5,105 | $425 |
| Calculation of radiation therapy dose | 26 | $4,339 | $59 |
| New patient visit (60+ min) | 23 | $4,313 | $188 |
| Design and construction of complex radiation treatment device | 15 | $3,856 | $113 |
| Complex radiation therapy planning | 25 | $3,553 | $142 |
| Continuing radiation therapy consultation per week | 18 | $3,175 | $81 |
Drugs they prescribed that Part D paid
$73,904
Pharmacies billed $73,904 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 134) in 2024. At or below the middle of the specialty; the typical radiation oncology clinician is at 11%.
107 generic and 27 brand-name prescriptions · $73,904 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Orgovyx | 27 | $72,513 | $2,686 |
| Tamsulosin | 40 | $440 | $11 |
| Triamcinolone Acetonide | 17 | $337 | $20 |
Year by year
| 2024 | 134 | 61 | 0% (0) | 20% | $73,904 |
| 2023 | 70 | 27 | 0% (0) | 0% | $1,197 |
| 2022 | 13 | 11 | 0% (0) | None | $316 |
| 2021 | 43 | 22 | 0% (0) | 0% | $993 |
| 2020 | 102 | 37 | None | 0% | $2,729 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Tamsulosin | 28 | $471 | $17 |
| Famotidine | 19 | $186 | $10 |
2021: 1 drug
| Tamsulosin | 25 | $563 | $23 |
2020: 3 drugs
| Tamsulosin | 36 | $1,208 | $34 |
| Famotidine | 12 | $356 | $30 |
| Omeprazole | 16 | $164 | $10 |
Money from drug and device companies
$231 in 2025
| 2025 | 5 | 9 | None | $231 |
| 2024 | 7 | 17 | None | $552 |
| 2023 | 2 | 2 | None | $120 |
| 2022 | 2 | 2 | $5,100 | $5,125 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pfizer | Xtandi | $57 | 2 payments
|
| Novartis Pharmaceuticals | Pluvicto | $55 | 2 payments
|
| Sumitomo Pharma America | Orgovyx | $54 | 2 payments
|
| Janssen Biotech | Erleada | $50 | 2 payments
|
| Regeneron Healthcare Solutions | Libtayo | $14 | 1 payment
|
See all 9 published payments
| Pfizer | Meals · 2025-10-27 | Xtandi | $28 |
| Sumitomo Pharma America | Meals · 2025-10-20 | Orgovyx | $28 |
| Novartis Pharmaceuticals | Meals · 2025-09-30 | Pluvicto | $33 |
| Janssen Biotech | Meals · 2025-09-29 | Erleada | $30 |
| Pfizer | Meals · 2025-07-14 | Xtandi | $29 |
| Regeneron Healthcare Solutions | Meals · 2025-04-29 | Libtayo | $14 |
| Janssen Biotech | Meals · 2025-04-16 | Erleada | $20 |
| Novartis Pharmaceuticals | Meals · 2025-02-25 | Pluvicto | $23 |
| Sumitomo Pharma America | Meals · 2025-02-19 | Orgovyx | $26 |
See earlier years (2024, 2023, 2022)
2024: $552
| Boston Scientific | Spaceoar Vue System - 10ml | $175 | 1 payment
|
| Regeneron Healthcare Solutions | Libtayo | $88 | 3 payments
|
| Pfizer | Xtandi | $85 | 5 payments
|
| Janssen Biotech | Erleada | $81 | 3 payments
|
| Coherus Biosciences | Udenyca | $53 | 2 payments
|
| Sumitomo Pharma America | Orgovyx | $47 | 2 payments
|
| Myriad Genetic Laboratories | Prolaris | $25 | 1 payment
|
2023: $120
| Boston Scientific | Spaceoar Vue System - 10ml | $101 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Tagrisso | $19 | 1 payment
|
2022: $5,125
| MIM Software | Contour Protege Ai | $5,100 | 1 payment
|
| Abbvie | Lupron Depot | $25 | 1 payment
|
Professional record
- NPI
- 1922505924
- Licence
- CA A166759California A166759: Current · expires 2027-11-30
- Trained
- Duke University School of Medicine, 2018
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2085R0001X (2085R0001X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2018-04-07
- NPI last updated
- 2024-03-06
- NPI record certified
- 2024-03-06
This is when the NPI record was last certified, not a medical board exam.